No shortage on file

TEVA-BUPRENORPHINE/NALOXONE

TEVA CANADA LIMITED

Quick answers

Is there a shortage of TEVA-BUPRENORPHINE/NALOXONE in Canada?

No. There is no current shortage of TEVA-BUPRENORPHINE/NALOXONE reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

DIN

02453908

Dosage Form

Tablet

Route

Sublingual

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

ACETAZONE FORTE C8

DIN 00834319

3.5MG · DIN 02438399

ACT CABERGOLINE

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163

ACT CIPROFLOXACIN

500MG · DIN 02247340

ACT CIPROFLOXACIN

750MG · DIN 02247341

ACT CIPROFLOXACIN

250MG · DIN 02247339

ACT CLOPIDOGREL

75MG · DIN 02303027

ACT DILTIAZEM CD

180MG · DIN 02370638

ACT DILTIAZEM CD

240MG · DIN 02370646